128 related articles for article (PubMed ID: 3005778)
1. Additional c-abl/bcr rearrangements in a CML patient exhibiting two ph1 chromosomes during blast crisis.
Bartram CR; de Klein A; Hagemeijer A; Carbonell F; Kleihauer E; Grosveld G
Leuk Res; 1986; 10(2):221-5. PubMed ID: 3005778
[TBL] [Abstract][Full Text] [Related]
2. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
Collins SJ
J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
[TBL] [Abstract][Full Text] [Related]
3. bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia.
De Klein A; Hagemeijer A; Bartram CR; Houwen R; Hoefsloot L; Carbonell F; Chan L; Barnett M; Greaves M; Kleihauer E
Blood; 1986 Dec; 68(6):1369-75. PubMed ID: 3465378
[TBL] [Abstract][Full Text] [Related]
4. Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.
Bartram CR; Janssen JW; Becher R; de Klein A; Grosveld G
J Exp Med; 1986 Nov; 164(5):1389-96. PubMed ID: 3464689
[TBL] [Abstract][Full Text] [Related]
5. Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.
Collins SJ; Groudine MT
Blood; 1987 Mar; 69(3):893-8. PubMed ID: 3545323
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome.
Stam K; Heisterkamp N; Grosveld G; de Klein A; Verma RS; Coleman M; Dosik H; Groffen J
N Engl J Med; 1985 Dec; 313(23):1429-33. PubMed ID: 3864009
[TBL] [Abstract][Full Text] [Related]
7. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
8. Philadelphia-positive chronic myeloid leukemia with a chromosome 22 breakpoint outside the breakpoint cluster region.
Selleri L; Narni F; Emilia G; Colò A; Zucchini P; Venturelli D; Donelli A; Torelli U; Torelli G
Blood; 1987 Nov; 70(5):1659-64. PubMed ID: 3478105
[TBL] [Abstract][Full Text] [Related]
9. C-abl and bcr are rearranged in a Ph1-negative CML patient.
Bartram CR; Kleihauer E; de Klein A; Grosveld G; Teyssier JR; Heisterkamp N; Groffen J
EMBO J; 1985 Mar; 4(3):683-6. PubMed ID: 3859408
[TBL] [Abstract][Full Text] [Related]
10. Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival.
Selleri L; Emilia G; Temperani P; Grassilli E; Zucchini P; Tagliafico E; Bonati A; Venezia L; Ferrari S; Torelli U
Leukemia; 1989 Jul; 3(7):538-42. PubMed ID: 2733455
[TBL] [Abstract][Full Text] [Related]
11. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
Gale RP; Canaani E
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5648-52. PubMed ID: 6091099
[TBL] [Abstract][Full Text] [Related]
12. Multiple molecular abnormalities in Ph1 chromosome positive acute lymphoblastic leukaemia.
Dreazen O; Klisak I; Jones G; Ho WG; Sparkes RS; Gale RP
Br J Haematol; 1987 Nov; 67(3):319-24. PubMed ID: 3479997
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
14. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
[TBL] [Abstract][Full Text] [Related]
15. Breakpoints in Philadelphia chromosome (Ph1)-positive leukemias.
Hirosawa S; Aoki N; Shibuya M; Onozawa Y
Jpn J Cancer Res; 1987 Jun; 78(6):590-5. PubMed ID: 3038812
[TBL] [Abstract][Full Text] [Related]
16. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).
Clark SS; McLaughlin J; Timmons M; Pendergast AM; Ben-Neriah Y; Dow LW; Crist W; Rovera G; Smith SD; Witte ON
Science; 1988 Feb; 239(4841 Pt 1):775-7. PubMed ID: 3422516
[TBL] [Abstract][Full Text] [Related]
17. Altered transcription of an oncogene in chronic myeloid leukaemia.
Canaani E; Gale RP; Steiner-Saltz D; Berrebi A; Aghai E; Januszewicz E
Lancet; 1984 Mar; 1(8377):593-5. PubMed ID: 6142307
[TBL] [Abstract][Full Text] [Related]
18. Structural organization of the bcr gene and its role in the Ph' translocation.
Heisterkamp N; Stam K; Groffen J; de Klein A; Grosveld G
Nature; 1985 Jun 27-Jul 3; 315(6022):758-61. PubMed ID: 2989703
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia.
Zitzelsberger H; Bauchinger M; Wilmanns W; Strauss PG
Cancer Genet Cytogenet; 1990 Jul; 47(2):219-25. PubMed ID: 2357696
[TBL] [Abstract][Full Text] [Related]
20. The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript.
Grosveld G; Verwoerd T; van Agthoven T; de Klein A; Ramachandran KL; Heisterkamp N; Stam K; Groffen J
Mol Cell Biol; 1986 Feb; 6(2):607-16. PubMed ID: 3023859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]